Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | AMGN | VRTX | REGN | GSK |
| Company | Adaptimmune Ther ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.0500 | 296.96 | 473.50 | 1,022.68 | 40.98 |
| High | 1.0500 | 299.34 | 481.35 | 1,030.82 | 41.22 |
| Low | 1.0200 | 295.30 | 472.61 | 1,017.87 | 40.79 |
| Last | 1.0400 | 298.50 | 479.03 | 1,026.55 | 41.11 |
| Change | unch | -2.58 | +3.24 | -1.12 | unch |
| % Change | unch | -0.86% | +0.68% | -0.11% | unch |
| Volume | 599,800 | 1,732,600 | 808,400 | 315,300 | 2,020,200 |
| 20-Day Average Volume | 2,148,735 | 2,208,510 | 1,225,005 | 385,200 | 4,113,450 |
| Previous Close | 1.0400 | 301.08 | 475.79 | 1,027.67 | 41.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0570 | 305.98 | 461.59 | 991.47 | 43.19 |
| 20-Day Raw Stochastic | 21.03% | 14.97% | 86.36% | 94.56% | 11.35% |
| 20-Day Relative Strength | 45.43% | 49.79% | 69.21% | 67.28% | 41.19% |
| Weighted Alpha | -33.28 | +25.95 | +42.93 | +34.11 | +15.43 |
| Today's Opinion | 8% Sell | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 8% Sell | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 24% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.97% since 06/06/24 | -2.35% since 06/06/24 | -1.34% since 06/06/24 | +2.57% since 06/06/24 | -1.04% since 06/06/24 |
| Low | 1.0100 on 06/11/24 | 295.30 on 06/13/24 | 472.61 on 06/13/24 | 992.22 on 06/10/24 | 40.78 on 06/13/24 |
| High | 1.0800 on 06/12/24 | 307.96 on 06/07/24 | 486.42 on 06/07/24 | 1,030.82 on 06/13/24 | 41.51 on 06/10/24 |
| 1-Month | |||||
| %Chg | -11.11% since 05/13/24 | -3.23% since 05/13/24 | +11.42% since 05/13/24 | +5.08% since 05/13/24 | -8.99% since 05/13/24 |
| Low | 0.9601 on 06/04/24 | 295.30 on 06/13/24 | 422.44 on 05/14/24 | 952.30 on 05/30/24 | 40.51 on 06/03/24 |
| High | 1.3400 on 05/16/24 | 321.44 on 05/15/24 | 486.42 on 06/07/24 | 1,030.82 on 06/13/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -34.59% since 03/13/24 | +8.16% since 03/13/24 | +15.93% since 03/13/24 | +6.33% since 03/13/24 | -5.19% since 03/13/24 |
| Low | 0.8721 on 04/18/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 1.6500 on 03/28/24 | 322.60 on 05/03/24 | 486.42 on 06/07/24 | 1,030.82 on 06/13/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +104.40% since 12/13/23 | +5.99% since 12/13/23 | +18.26% since 12/13/23 | +17.17% since 12/13/23 | +11.89% since 12/13/23 |
| Low | 0.4300 on 12/21/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 838.46 on 12/21/23 | 35.87 on 12/15/23 |
| High | 2.0500 on 03/08/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,030.82 on 06/13/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 256,698 | 161,509,840 | 122,779,040 | 113,234,840 | 85,198,008 |
| Shares Outstanding, K | 246,825 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 60,280,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -113,870,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 5,680,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -48,500,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 2.33 | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 05/15/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/15/24 | 08/01/24 | 08/06/24 | 08/01/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.14 | 31.97 | 27.23 | 10.16 |